Dickstein G, Barzilai D
Arch Intern Med. 1982 Aug;142(8):1544-5.
A 50-year-old man, suffering from a large pituitary adenoma and panhypopituitarism, was found to have severely elevated thyrotrophin (thyroid-stimulating hormone [TSH]) levels (greater than 20.2 microunits/mL). The thyroxine (T4) level was low (less than 3.0 micrograms/dL). Thyroid sodium iodide I 131 uptake was low (5% at 24 hours). A TSH test result was normal, with a 24-hour 131I uptake of 52% and a normal-looking thyroid gland on scintiscan. After surgical removal of the pituitary chromphobe adenoma, T4 levels returned to normal (6.8 micrograms/dL) and TSH levels improved substantially (9.0 microunits/mL). Findings from repeated 131I uptake tests were normal (22% at 24 hours). Other pituitary functions improved also. These results suggest that the patient had biologically inactive TSH produced by the tumor. Removal of the tumor probably enabled recovery of the active TSH with the return of normal thyroid uptake and T4 production. Whenever hypothyroidism and high levels of TSH coexist with pituitary dysfunction, a TSH test is needed to distinguish between primary hypothyroidism and hypothyroidism secondary to biologic inactive TSH.
一名50岁男性,患有大型垂体腺瘤和全垂体功能减退症,其促甲状腺素(促甲状腺激素[TSH])水平严重升高(大于20.2微单位/毫升)。甲状腺素(T4)水平较低(低于3.0微克/分升)。甲状腺碘I 131摄取率较低(24小时时为5%)。促甲状腺激素检测结果正常,24小时131I摄取率为52%,闪烁扫描显示甲状腺外观正常。手术切除垂体嫌色细胞瘤后,T4水平恢复正常(6.8微克/分升),TSH水平显著改善(9.0微单位/毫升)。重复进行的131I摄取试验结果正常(24小时时为22%)。其他垂体功能也有所改善。这些结果表明,该患者的肿瘤产生了生物学上无活性的促甲状腺激素。切除肿瘤可能使活性促甲状腺激素得以恢复,甲状腺摄取和T4产生也恢复正常。每当甲状腺功能减退症和高水平促甲状腺激素与垂体功能障碍同时存在时,需要进行促甲状腺激素检测以区分原发性甲状腺功能减退症和继发于生物学无活性促甲状腺激素的甲状腺功能减退症。